GlassScriptPhysician profile
Justin M Dunn
NPI 1902002843
$133,025.03
in general payments reported to CMS, 2019-2025
25 companies · $52K in 2025
The $52K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $17K · 2021: $17K · 2022: $8,303 · 2023: $8,115 · 2024: $14K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $10K · Food and Beverage: $7,939 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,534.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,500.00 |
| Travel and Lodging | $10,287.77 |
| Food and Beverage | $7,938.89 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71,496.06 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $23,083.67 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Shockwave Medical, INC | $13,847.30 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $9,004.36 | 2019-2023 | |
| Boston Scientific Corporation | $7,157.70 | 2020-2025 | Vitalyst, General - Therapies, Watchman Flx |
| Medtronic, INC. | $4,013.96 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Euphora |
| Abiomed | $1,305.41 | 2019-2025 | Impella |
| Abbott Laboratories | $1,003.09 | 2019-2025 | Diamondback Coronary, Mitraclip, Amplatzer Amulet |
| Inari Medical, INC. | $832.10 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $406.54 | 2019-2025 | Indigo System |
| Cardiovascular Systems INC. | $361.43 | 2019-2023 | Diamondback Coronary |
| Medtronic Vascular, INC. | $95.64 | 2019 | |
| Cordis US Corp. | $88.28 | 2023-2024 | Mynx Control, Saber |
| Atricure, INC. | $51.70 | 2023-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| E.R. Squibb & Sons, L.L.C. | $49.07 | 2022-2024 | Eliquis |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37.77 | 2020 | |
| Cardiva Medical, INC. | $35.59 | 2022-2024 | Optowire |
| W. L. Gore & Associates, INC. | $33.64 | 2024-2025 | Gore Cardioform Septal Occluder |
| Terumo Medical Corporation | $29.92 | 2022 | |
| Csl Behring | $20.26 | 2022 | |
| Getinge USA Sales, LLC | $19.34 | 2020 | |
| Bard Peripheral Vascular, INC. | $14.89 | 2020 | |
| Ekos Corporation | $13.79 | 2019 | |
| Angiodynamics, INC. | $13.52 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $10.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.